[Role of antikaliuretics and catecholamines in the prevention of cardiac necroses of metabolic origin].
D000305:Adrenal Cortex Hormones; D000584:Amiloride; D000818:Animals; D002395:Catecholamines / Q000627:therapeutic use*; D004074:Digitoxin; D004232:Diuretics / Q000627:therapeutic use*; D004837:Epinephrine; D006331:Heart Diseases / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D007668:Kidney / Q000378:metabolism; D008274:Magnesium / Q000627:therapeutic use; D008659:Metabolic Diseases / Q000150:complications; D009336:Necrosis; D009821:Oils; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011188:Potassium / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011189:Potassium Chloride / Q000494:pharmacology; D011433:Propranolol / Q000627:therapeutic use; D011719:Pyrazines / Q000494:pharmacology; D051381:Rats; D012964:Sodium; D013312:Stress, Physiological
D000305:Adrenal Cortex Hormones; D002395:Catecholamines; D004232:Diuretics; D009821:Oils; D011719:Pyrazines; D010643:Phenoxybenzamine; D011189:Potassium Chloride; D000584:Amiloride; D012964:Sodium; D011433:Propranolol; D004074:Digitoxin; D008274:Magnesium; D011188:Potassium; D004837:Epinephrine
Rôle des antikaliurétiques et des catécholamines dans la prévention de nécroses cardiaques d'origine métabolique.